IEX · 8-K · 20261028PR000026

Segment Revenue Performance

IDEX CORP /DE/ · 2026-10-28 · Importance 48 · Surprise 40

Health & Science Technologies third-quarter sales increased $52.5 million, or 14%, to $433.5 million; organic sales grew 13%. Higher volumes, primarily from AI-driven demand in data center power and semiconductor markets, and strength in space and defense supported performance, alongside positive price. The July 2025 Micro-LAM acquisition contributed to reported HST sales growth.